ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001